IRIS

Sfoglia per Rivista  HAEMATOLOGICA

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Mostrati risultati da 32 a 51 di 106
Titolo Data di pubblicazione Autore(i) File
Gene polymorphisms in folate metabolizing enzymes in adult acute lymphoblastic leukemia: effects on methotrexate-related toxicity and survival. 1-gen-2009 Ongaro, A; De Mattei, M; Rigolin, G; Ambrosio, C; Di Raimondo, F; Pellati, A; Masieri, Ff; Caruso, A; Catozzi, L; Gemmati, D.; DELLA PORTA, MATTEO GIOVANNI
Genome-wide analysis of copy number changes and loss of heterozygosity in myelodysplastic syndrome with del(5q) using high-density single nucleotide polymorphism arrays. 1-gen-2008 DELLA PORTA, MATTEO GIOVANNI
GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) PREVENTS DOSE-LIMITING NEUTROPENIA IN LYMPHOMA PATIENTS RECEIVING STANDARD-DOSE CHEMOTHERAPY 1-gen-1995 Dotti, G; CARLO-STELLA, C.; Mangoni, L; Cottafavi, L; Caramatti, C; Almici, C; Rizzoli, V
Hematologic responses with deferasirox therapy in transfusion-dependent myelodysplastic syndromes patients. 1-gen-2012 Gattermann, N.; Finelli, C.; Fenaux, P.; Stadler, M.; Guerci-Bresler, A.; Schmid, M.; Taylor, K.; Vassilieff, D.; Habr, D.; Marcellari, A.; Roubert, B.; Rose, C.; Della Porta, M. G.
Hemostatic alterations in COVID-19 1-gen-2021 Peyvandi, Flora; Artoni, Andrea; Novembrino, Cristina; Aliberti, Stefano; Panigada, Mauro; Boscarino, Marco; Gualtierotti, Roberta; Rossi, Federica; Palla, Roberta; Martinelli, Ida; Grasselli, Giacomo; Blasi, Francesco; Tripodi, Armando
HUMAN PERIPHERAL-BLOOD MONONUCLEAR CELL SUBFRACTIONATION USING COUNTERFLOW CENTRIFUGATION ELUTRIATION 1-gen-1991 Almici, C; Mangoni, L; CARLO-STELLA, C.; Rizzoli, V
Identification of six novel mutations causing coagulation factor V deficiency 1-gen-2006 Dall’Osso, C; Asselta, R; Duga, S; Locatelli, N; Peyvandi, F; Skurzak, S; Malcovati, M; Tenchini, Ml
Ifosfamide, gemcitabine, and vinorelbine: a now induction regimen for refractory and relapsed Hodgkin's lymphoma 1-gen-2007 Santoro, A; Magagnoli, M; Spina, M; Pinotti, G; Siracusano, L; Michieli, M; Nozza, A; Sarina, B; Morenghi, E; Castagna, L; Tirelli, U; Balzarotti, M
IL-1R8, A NEGATIVE REGULATOR OF INFLAMMATION AND CHECKPOINT MOLECULE 1-gen-2018 Garlanda, C
Immunophenotypic analysis of erythroid dysplasia in myelodysplastic syndromes. A report from the IMDSFlow working group. 1-gen-2017 Westers, Tm; Cremers, Em; Oelschlaegel, U; Johansson, U; Bettelheim, P; Matarraz, S; Orfao, A; Moshaver, B; Brodersen, Le; Loken, Mr; Wells, Da; Subirá, D; Cullen, M; Te Marvelde, Jg; van der Velden, Vh; Preijers, Fw; Chu, Sc; Feuillard, J; Guérin, E; Psarra, K; Porwit, A; Saft, L; Ireland, R; Milne, T; Béné, Mc; Witte, Bi; Della Porta, M; Kern, W; van de Loosdrecht, Aa
Impact of the degree of anemia on the outcome of patients with myelodysplastic syndrome and its integration into the WHO classification-based Prognostic Scoring System (WPSS) 1-gen-2011 DELLA PORTA, MATTEO GIOVANNI
IN VITRO GROWTH OF BONE MARROW-DERIVED MULTIPOTENT AND LINEAGE-RESTRICTED HEMATOPOIETIC PROGENITOR CELLS IN MYELODYSPLASTIC SYNDROMES 1-gen-1989 CARLO STELLA, C.; Cazzola, M; Bernasconi, P; Bergamaschi, G; Dezza, L; Pedrazzoli, P; Rosti, V; Tomaselli, S; Zappone, E
Inappropriately low hepcidin levels in patients with myelodysplastic syndrome carrying a somatic mutation of SF3B1 1-gen-2013 DELLA PORTA, MATTEO GIOVANNI
INTERFERONS AS BIOLOGIC MODULATORS OF HEMATOPOIETIC-CELL PROLIFERATION AND DIFFERENTIATION 1-gen-1988 CARLO STELLA, C.; Cazzola, M
INVITRO AND INVIVO EFFECTS OF RECOMBINANT INTERFERON GAMMA ON THE GROWTH OF HEMATOPOIETIC PROGENITOR CELLS FROM PATIENTS WITH MYELODYSPLASTIC SYNDROME 1-gen-1989 Rosti, V; CARLO-STELLA, C.; Pedrazzoli, P; Cazzola, M
INVITRO MEGAKARYOCYTOPOIESIS IN PATIENTS WITH HIV-RELATED THROMBOCYTOPENIC PURPURA 1-gen-1988 CARLO-STELLA, C.; Bergamaschi, G; Nalli, G; Cazzola, M
Isolated massive meningeal progression in aggressive non Hodgkin's lymphoma 1-gen-2002 Magagnoli, M; Nozza, A; Santoro, A
Italian real-life experience with brentuximab vedotin: results of a large observational study of 40 cases of relapsed/refractory systemic anaplastic large cell lymphoma 1-gen-2017 Broccoli, A; Pellegrini, C; Di Rocco, A; Puccini, B; Patti, C; Gini, G; Mannina, D; Tani, M; Rusconi, C; Romano, A; Vanazzi, A; Botto, B; Carlo Stella, C; Hohaus, S; Musto, P; Mazza, P; Molica, S; Corradini, P; Fama, A; Gaudio, F; Merli, M; Gravetti, A; Gritti, G; Arcari, A; Tosi, P; Liberati, Am; Pinto, A; Pavone, V; Gherlinzoni, F; Naso, V; Volpetti, S; Trentin, L; Goldaniga, Mc; Bonfichi, M; De Renzo, A; Schiavotto, C; Spina, M; Storti, S; Carella, Am; Stefoni, V; Argnani, L; Zinzani, Pl
KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL study In corso di stampa Ferrero, S; Rossi, D; Rinaldi, A; Bruscaggin, A; Spina, V; Eskelund, C W; Evangelista, A; Moia, R; Kwee, I; Dahl, C; Di Rocco, A; Stefoni, V; Diop, F; Favini, C; Ghione, P; Mahmoud, A M; Schipani, M; Kolstad, A; Barbero, D; Novero, D; Paulli, M; Zamò, A; Jerkeman, M; Gomez Da Silva, M; Santoro, A; Molinari, A; Ferreri, A; Gronbaek, K; Piccin, A; Cortellazzo, S; Bertoni, F; Ladetto, M; Gaidano, G
Late appearance of the 11q22.3-23.1 deletion involving the ATM locus in B-cell chronic lymphocytic leukemia and related disorders. Clinico-biological significance. 1-gen-2002 Cuneo, A; Bigoni, R; Rigolin, Gm; Roberti, Mg; Bardi, A; Cavazzini, F; Milani, R; Minotto, C; Tieghi, A; Agostini, P; Tammiso, E; Negrini, M; Castoldi, G.; DELLA PORTA, MATTEO GIOVANNI
Mostrati risultati da 32 a 51 di 106
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile